OptimizeRx (OPRX) Invested Capital (2010 - 2026)

OptimizeRx has disclosed Invested Capital across 11 years of filings, most recently posting $152.0 million for Q2 2026.

• In Q2 2026, Invested Capital changed 0.1% year-over-year to $152.0 million; the TTM figure through Jun 2026 stood at $152.0 million (changed 0.1% YoY), while the FY2025 annual figure was $158.8 million, up 3.62% from the prior year.
• Invested Capital came in at $152.0 million for Q2 2026 at OptimizeRx, down from $155.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $162.8 million in Q4 2023 to a low of $149.7 million in Q3 2024.
• Average Invested Capital over 4 years is $155.1 million, with a median of $154.4 million recorded in 2025.
• Year-over-year, Invested Capital fell 5.83% in 2024 and climbed 3.62% in 2025.
• Over 4 years, Invested Capital stood at $162.8 million in 2023, then slipped by 5.83% to $153.3 million in 2024, then climbed by 3.62% to $158.8 million in 2025, then fell by 4.29% to $152.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $152.0 million in Q2 2026, $155.2 million in Q1 2026, and $158.8 million in Q4 2025.